Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02915055 · ClinicalTrials.gov registry record
NSAID vs. Narcotics
A clinical trial of Multimodal Analgesia and Nonsteroidal Anti-inflammatory Drugs, sponsored by NYU Langone Health.
- Completed
- Registry status
- 77
- Enrollment target
- 1
- Study location
NCT02915055: Completed study of Multimodal Analgesia and Nonsteroidal Anti-inflammatory Drugs, sponsored by NYU Langone Health.
NCT02915055 is a study of Multimodal Analgesia and Nonsteroidal Anti-inflammatory Drugs that has completed, run by NYU Langone Health. The registered enrollment target is 77 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02915055, a study of Multimodal Analgesia and Nonsteroidal Anti-inflammatory Drugs, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a single-center, prospective observational study. The study will compare post-operative pain scores and narcotic consumption between two groups of patients - one cohort will receive ibuprofen (Motrin) and Percocet (to be used as needed) while the other cohort will receive only Percocet. Both pain management options are considered to be standard of care. The primary objective of the study is to compare patients' reported pain and narcotic use following meniscectomy, and determine if NSAIDs can provide adequate pain relief.
Primary Outcome
Scale consisting of a drawn line from 0 to 100 - you will be asked to mark where you believe your pain is (100 being worse pain).
Conditions Studied
Interventions
- DRUG Ibuprofen 600 mg
- DRUG standard oxycodone/acetaminophen
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2017-03-01 |
What the finished NCT02915055 record still lists
NCT02915055 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 77 participants, a relatively small participant target.
The record links to 2 conditions, with Multimodal Analgesia appearing as the primary indexed condition, and to 2 interventions - of which Ibuprofen 600 mg is the first listed.
NCT02915055 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02915055 about?
NCT02915055 is a clinical study titled "NSAID vs. Narcotics". This will be a single-center, prospective observational study. The study will compare post-operative pain scores and narcotic consumption between two groups of patients - one cohort will receive ibuprofen (Motrin) and Percocet (to be used as needed) while the other cohort will receive only Percocet....
What is the current status of trial NCT02915055?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2016-09-01. Estimated completion is 2017-03-01.
What conditions does trial NCT02915055 study?
This clinical trial studies the following conditions: Multimodal Analgesia, Nonsteroidal Anti-inflammatory Drugs.
What interventions are being tested in trial NCT02915055?
The interventions under investigation include: Ibuprofen 600 mg (DRUG), standard oxycodone/acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02915055?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02915055 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multimodal Analgesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI